Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects

George Anderson; Michael Maes

doi:10.1007/s11011-012-9307-9

Related publications

Article2020

Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders

Henk Temmingh, Wim van den Brink, Fleur M. Howells, Goodman Sibeko, Dan Joseph Stein

Article2015

Comparison of psychotic bipolar disorder, schizoaffective disorder, and schizophrenia: an international, multisite study

Leonardo Tondo, Gustavo Vázquez, Christopher Baethge, C. Baronessa, L Bolzani, Alexia E. Koukopoulos, Lorenzo Mazzarini, Andréa Murru, Isabella Pacchiarotti, Marco Pinna, Paola Salvatore, Gabriele Sani, Valerio Selle, Gianfranco Spalletta, Paolo Girardi, Mauricio Tohen, Eduard Vieta, Ross J. Baldessarini

Article1992

Drug derived radicals: mediators of the side effects of anti-inflammatory drugs?

Barry Halliwell, Patricia Evans, Harsimran Kaur, S Chirico

Article2017

Neurocognition in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia

Estela Jiménez‐López, Ana Isabel Aparicio, Eva María Sánchez‐Morla, Roberto Rodríguez–Jiménez, Eduard Vieta, José Luis Santos

Article2018

Psychosocial functioning in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia

Estela Jiménez‐López, Eva María Sánchez‐Morla, Ana Isabel Aparicio, Ana López-Villarreal, Vicente Martínez‐Vizcaíno, Roberto Rodríguez–Jiménez, Eduard Vieta, José Luis Santos